Literature DB >> 8599213

Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6.

T Crook1, R L Ludwig, N J Marston, D Willkomm, K H Vousden.   

Abstract

The activity of the p53 tumor suppressor protein is regulated, at least in part, through the stability of the protein. p53 degradation in normal cells is controlled by ubiquitin-dependent proteolysis, and activation of p53 following DNA damage is associated with an increase in the stability of the protein. The human papillomavirus-encoded E6 protein abrogates p53 function by targeting it for rapid degradation, also through the ubiquitin pathway. Although the p53 protein is ubiquitinated following interaction with E6, we show here that none of the lysine residues within p53 are specifically required for E6-targeted degradation. Mutation of lysine residues within the C-terminus of p53 resulted in resistance to E6-mediated degradation in vitro, although the ability of the two proteins to form a complex was not affected. The same mutant was efficiently targeted for degradation in cells, however, illustrating a lack of correlation between the in vitro and the in vivo assays.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8599213     DOI: 10.1006/viro.1996.0115

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.

Authors:  M S Rodriguez; J M Desterro; S Lain; D P Lane; R T Hay
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis.

Authors:  Stijn Heessen; Ainars Leonchiks; Natalia Issaeva; Anatoly Sharipo; Galina Selivanova; Maria G Masucci; Nico P Dantuma
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  Mdm2 directs the ubiquitination of beta-arrestin-sequestered cAMP phosphodiesterase-4D5.

Authors:  Xiang Li; George S Baillie; Miles D Houslay
Journal:  J Biol Chem       Date:  2009-04-16       Impact factor: 5.157

4.  Regulation of Mdm2-directed degradation by the C terminus of p53.

Authors:  M H Kubbutat; R L Ludwig; M Ashcroft; K H Vousden
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

5.  C-terminal ubiquitination of p53 contributes to nuclear export.

Authors:  M A Lohrum; D B Woods; R L Ludwig; E Bálint; K H Vousden
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

6.  Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies.

Authors:  Mario A Pennella; Yue Liu; Jennifer L Woo; Chongwoo A Kim; Arnold J Berk
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

7.  Gps2, a protein partner for human papillomavirus E6 proteins.

Authors:  Y Y Degenhardt; S J Silverstein
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function.

Authors:  R L Ludwig; S Bates; K H Vousden
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

9.  Polyubiquitylation of histone H2B.

Authors:  Fuqiang Geng; William P Tansey
Journal:  Mol Biol Cell       Date:  2008-06-18       Impact factor: 4.138

10.  Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6.

Authors:  S Camus; S Menéndez; C F Cheok; L F Stevenson; S Laín; D P Lane
Journal:  Oncogene       Date:  2007-01-15       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.